These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27758063)

  • 1. Course of serum autoantibodies in patients after acute angle-closure glaucoma attack.
    Lorenz K; Beck S; Keilani MM; Wasielica-Poslednik J; Pfeiffer N; Grus FH
    Clin Exp Ophthalmol; 2017 Apr; 45(3):280-287. PubMed ID: 27758063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Analysis of Serum Autoantibody-Reactivities in Patients with Primary Open Angle Glaucoma and Optic Disc Hemorrhage.
    Lorenz K; Beck S; Keilani MM; Wasielica-Poslednik J; Pfeiffer N; Grus FH
    PLoS One; 2016; 11(12):e0166813. PubMed ID: 28030545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of antibody response to heat shock proteins and tissue antigens in an ocular ischemia model.
    Joachim SC; Wax MB; Boehm N; Dirk DR; Pfeiffer N; Grus FH
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3468-74. PubMed ID: 21310899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal ganglion cells recognized by serum autoantibody against gamma-enolase found in glaucoma patients.
    Maruyama I; Ohguro H; Ikeda Y
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1657-65. PubMed ID: 10845582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States.
    Grus FH; Joachim SC; Bruns K; Lackner KJ; Pfeiffer N; Wax MB
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):968-76. PubMed ID: 16505031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of serum antibody against neuron-specific enolase in glaucoma patients.
    Ikeda Y; Maruyama I; Nakazawa M; Ohguro H
    Jpn J Ophthalmol; 2002; 46(1):13-7. PubMed ID: 11853708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser peripheral iridotomy with and without iridoplasty for primary angle-closure glaucoma: 1-year results of a randomized pilot study.
    Sun X; Liang YB; Wang NL; Fan SJ; Sun LP; Li SZ; Liu WR
    Am J Ophthalmol; 2010 Jul; 150(1):68-73. PubMed ID: 20472226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex antibody profile changes in an experimental autoimmune glaucoma animal model.
    Joachim SC; Grus FH; Kraft D; White-Farrar K; Barnes G; Barbeck M; Ghanaati S; Cao S; Li B; Wax MB
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4734-42. PubMed ID: 19458332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical roles of serum autoantibody against neuron-specific enolase in glaucoma patients.
    Maruyama I; Ikeda Y; Nakazawa M; Ohguro H
    Tohoku J Exp Med; 2002 Jul; 197(3):125-32. PubMed ID: 12365552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectivity of Nd Yag PI in treatment of acute primary angle closure glaucoma.
    Singh P; Rijal AP
    Nepal Med Coll J; 2014 Sep; 16(1):45-9. PubMed ID: 25799811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of primary angle closure suspects after laser peripheral iridotomy using ultrasound biomicroscopy and A-scan biometry for a period of 2 years.
    Ramani KK; Mani B; George RJ; Lingam V
    J Glaucoma; 2009 Sep; 18(7):521-7. PubMed ID: 19745666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial management of acute primary angle closure: a randomized trial comparing phacoemulsification with laser peripheral iridotomy.
    Husain R; Gazzard G; Aung T; Chen Y; Padmanabhan V; Oen FT; Seah SK; Hoh ST
    Ophthalmology; 2012 Nov; 119(11):2274-81. PubMed ID: 22885123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between extent of preexisting organic angle closure and long-term outcome after laser peripheral iridotomy in eyes with primary angle closure.
    Sawada A; Yamamoto T
    J Glaucoma; 2012 Mar; 21(3):174-9. PubMed ID: 21336152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of primary angle closure glaucoma management.
    Alipanahi R; Sayyahmelli S
    J Pak Med Assoc; 2011 Jul; 61(7):636-9. PubMed ID: 22204235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term outcomes of laser peripheral iridectomy for primary angle closure glaucoma].
    Bian AL; Zhao JL; Zhou Q; Zhang Y; Liu XL; Mao J
    Zhonghua Yan Ke Za Zhi; 2009 Dec; 45(12):1099-104. PubMed ID: 20193433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular biometry in the subtypes of angle closure: an anterior segment optical coherence tomography study.
    Moghimi S; Vahedian Z; Fakhraie G; Ghaffari R; Eslami Y; Jabarvand M; Zarei R; Mohammadi M; Lin S
    Am J Ophthalmol; 2013 Apr; 155(4):664-673, 673.e1. PubMed ID: 23246271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens.
    Joachim SC; Reichelt J; Berneiser S; Pfeiffer N; Grus FH
    Graefes Arch Clin Exp Ophthalmol; 2008 Apr; 246(4):573-80. PubMed ID: 18193265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trabeculectomy in patients with primary angle-closure glaucoma.
    Chen YH; Lu DW; Cheng JH; Chen JT; Chen CL
    J Glaucoma; 2009 Dec; 18(9):679-83. PubMed ID: 20010247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression in primary angle closure eyes.
    Sihota R; Rao A; Gupta V; Srinivasan G; Sharma A
    J Glaucoma; 2010 Dec; 19(9):632-6. PubMed ID: 20164791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of autoantibodies against human retinal antigens in sera of patients with glaucoma and ocular hypertension.
    Reichelt J; Joachim SC; Pfeiffer N; Grus FH
    Curr Eye Res; 2008 Mar; 33(3):253-61. PubMed ID: 18350436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.